FibroGen(FGEN) - 2025 Q1 - Earnings Call Presentation

FibroGen Reports First Quarter 2025 Financial Results May 12, 2025 Forward-Looking Statements This presentation contains contains forward-looking statements regarding FibroGen's strategy, future plans and prospects, including statements regarding its commercial products and clinical programs and those of its collaboration partners Fortis and UCSF. These forward- looking statements include, but are not limited to, statements regarding the efficacy, safety, and potential clinical or commercial success of Fibr ...